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Purpose: Phantom motor execution (PME) facilitated by augmented/virtual reality (AR/
VR) and serious gaming (SG) has been proposed as a treatment for phantom limb pain
(PLP). Evidence of the efﬁcacy of this approach was obtained through a clinical trial
involving individuals with chronic intractable PLP affecting the upper limb, and further
evidence is currently being sought with a multi-sited, international, double blind, rando-
mized, controlled clinical trial in upper and lower limb amputees. All experiments have been
conducted in a clinical setting supervised by a therapist. Here, we present a series of case
studies (two upper and two lower limb amputees) on the use of PME as a self-treatment. We
explore the beneﬁts and the challenges encountered in translation from clinic to home use
with a holistic, mixed-methods approach, employing both quantitative and qualitative meth-
ods from engineering, medical anthropology, and user interface design.
Patients and Methods: All patients were provided with and trained to use a myoelectric
pattern recognition and AR/VR device for PME. Patients took these devices home and used
them independently over 12 months.
Results: We found that patients were capable of conducting PME as a self-treatment and
incorporated the device into their daily life routines. Use patterns and adherence to PME practice
were not only driven by the presence of PLP but also inﬂuenced by patients’ perceived need and
social context. The main barriers to therapy adherence were time and availability of single-use
electrodes, both of which could be resolved, or attenuated, by informed design considerations.
Conclusion: Our ﬁndings suggest that adherence to treatment, and thus related outcomes, could
be further improved by considering disparate user types and their utilization patterns. Our study
highlights the importance of understanding, from multiple disciplinary angles, the tight coupling
and interplay between pain, perceived need, and use of medical devices in patient-initiated therapy.
Keywords: phantom limb pain, neuropathic pain, augmented reality, phantom motor
execution, ethnography, user interaction design
Introduction
Phantom limb pain (PLP) has been deﬁned by the International Association for the Study
of Pain (IASP) based on its perceived location; the phantom limb (IASP global year
against neuropathic pain (2014–2015)). However, phantom limb pain (hereafter referred
to as PLP) has a complex etiology and thus can be elicited by different sources, such as
nociceptive (neuromas) and/or neuropathic.1 Promising results have recently been
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published using surgical innervations to address nociceptive
sources (neuroma pain),2,3 but neuropathic causes remain
unresolved,4 even by pharmacological interventions.5 This
work is focused on neuropathic PLP and a non-invasive, non-
pharmacological method to treat it.
PLP has been hypothesized as arising from the stochas-
tic entanglement of the pain neurosignature with impaired
sensorimotor circuitry.1 In accordance with the implica-
tions of this hypothesis, a myoelectric pattern recognition
(MPR) device was developed to promote Phantom Motor
Execution (PME) as a treatment for PLP. PME engages
motor neural circuitry in the central and peripheral nervous
systems, ultimately resulting in the activation of the mus-
culature at the residual limb while attempting phantom
movements. By extracting motor intention from the
stump’s muscular activity, one can provide patients with
real-time feedback utilizing Augmented and Virtual
Reality (AR/VR), as well as serious gaming (SG).6
Preliminary evidence of the efﬁcacy of this approach
was obtained through a clinical trial involving individuals
with intractable PLP affecting the upper limb,7 and further
evidence is currently being sought with a multi-sited, inter-
national, double blind, randomized, controlled clinical trial
with upper and lower limb amputees.8 All these experi-
ments have been conducted in a clinical setting supervised
by a therapist. However, when considering how the reduc-
tion of PLP relates to acquisition and maintenance of motor
skills of the phantom limb, the question naturally emerges
as to whether this treatment approach could be self-
administered at home. The learning of phantom motor skills
requires practice and occasional rehearsal is likely neces-
sary to maintain said skills. With this in mind, we deemed it
sensible to explore the feasibility of embedding PME in
patients’ home environments and daily life.
Studies of prescribed home use therapies have sug-
gested that approximately 65 percent of patients will be
non-adherent to some degree, due to factors such as life-
style changes, complexity of the prescribed regime, lack of
ability to ﬁt the regime into normal routines, and the
patient’s internal level of motivation to do the treatment.9
We were interested in understanding how these extrinsic
lifestyle and personal factors interact with the patient’s
perceived need for the treatment as governed by pain
levels, producing particular patterns of use and adherence.
In this manuscript, we present a series of four case
studies on the use of Phantom Motor Execution as a self-
treatment strategy for PLP. These case reports, involving
two transhumeral and two transfemoral amputees, describe
these patient’s experiences using the therapy in their
homes. We aimed to explore the beneﬁts and the transla-
tional challenges encountered in the transition from clinic
to home use. We hypothesized that home therapy yields
efﬁcacious results in pain reduction comparable to ﬁndings
observed in the clinic, with the advantages of independent,
customizable, personalized use outside of the hospital, as
patients adapt the therapy to their individual preferences
and lifestyles. In developing a more holistic understanding
of how patients use the device at home and motivate
themselves to perform the therapy, design recommenda-
tions can be drawn for future development of at home-
based therapy systems.
In this study, we employ a multidisciplinary approach,
enlisting the methodical and analytical tools of
a biomedical engineer, medical anthropologist, and user
interface designer. We chose this approach to elucidate not
only the technical and quantitative data surrounding
patients’ in-home use of the therapy, but also to understand
qualitatively the patient’s relationship with their device
and therapy program and develop design requirements
for future in-home device development. Medical anthro-
pology is the study of how social, cultural, biological, and
structural factors intersect and interact with people’s
experiences of health, illness, medical treatments, and
differentially distributed access to well-being. The primary
methodological tool of anthropology is ethnography – sus-
tained, immersive, long-term exposure of the anthropolo-
gist to individual’s lives and worlds – in the endeavor to
get as close as possible to understanding their ﬁrsthand
experiences, practices, and values. Medical anthropology
thus has the potential to complement, deepen, and even
sometimes challenge the study of medical interventions
through a more holistic lens.
Our study engages ethnographic insights into the lives
of patients, involvement of family members, and beha-
vioral patterns surrounding therapy to contextualize the
clinical and quantitative perspectives. This multidisciplin-
ary approach allows us to identify patterns otherwise over-
looked using one method alone, offering an expanded
appreciation of the many interrelated variables (physical,
social, and structural) that drive patient home therapy
regimes. Our study thus offers a methodological example
of how engineers can work alongside interaction designers
and anthropologists to produce a more deeply situated
understanding of medical device development, use and
efﬁcacy, with the ﬁnal aim of bringing such a device into
the hands of the patient.
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Materials and Methods
Design
All patients were provided with and trained to use a MPR
and AR/VR device in a laboratory and/or clinical setting.
Patients then took these devices home and used them
freely and independently over the course of 12 months.
At the end of the treatment period, the research group
interviewed the subjects in an in-home setting and gath-
ered the training data stored by the training software. The
study was approved by the Regional Ethical Review Board
in Gothenburg and was carried out in accordance with the
relevant guidelines and regulations. All subjects provided
their written informed consent to take part in the study and
its publication.
Participants
Four limb loss patients (2 upper and 2 lower limb ampu-
tees) participated in this study. In the following we
describe their backgrounds and their introductions to
PME treatment.
Subject 1
Subject 1 (S1) is a 77-year-old man (born in 1941) who
underwent an acute transhumeral amputation over 50 years
ago (1964) in a motor vehicle accident, at age 24. S1
suffered from incapacitating phantom limb pain soon
after the amputation, which severely impacted his sleep,
mood, and ability to work. S1 experienced limited but
unsustained PLP relief from hypnosis and mirror therapy.
S1 was the ﬁrst patient to undergo the PME treatment in
2013, resulting in the relief of nearly 50 years of PLP.6 S1
was also the ﬁrst person to use the device in-home, outside
the clinic or laboratory.
Subject 2
Subject 2 (S2) is a 56-year-old man who lost his arm in 2011
in a tractor accident. He developed phantom limb pain
directly after the accident, which he described manifesting
as his hand clenched tightly in a ﬁst. In 2014, he commenced
PME therapy joining the ﬁrst clinical trial on PME.7 S2 had
consistently taken morphine since the accident to help man-
age his PLP. Before joining the clinical trial, he used to take
morphine pills in combination with morphine plasters, how-
ever by the end of his participation in the clinical trial he
abandoned the plasters. He noticed that the valence of his
pain changes with the seasons, getting markedly worse dur-
ing winter, and he is currently using oxynorm (5mg/daily) to
supplement his pain management.
Subject 3
Subject 3 (S3) is a 72-year old man who lost his leg in
1985 in a tractor accident. For the ﬁrst 19 years after his
accident, he did not experience debilitating phantom limb
pain. Yet in 2014 S3 started to experience “unbearable”
pain. The patient subsequently took part in a study using
PME in lower extremities, which resulted in a signiﬁcant
decrease in PLP.10 Following sustained PME treatment,
the patient reported that his pain has returned to the level
it was 20 years ago, “a manageable place.” S3’s pain was
reported as worst in the middle of the night, when nothing
else can distract him. As his son described, “my father is
incredibly active. When he is always moving his body, he
can’t feel the pain. He once told me he wished he could
just keep busy working for 24 hrs straight.”
Subject 4
Subject 4 (S4), at 28 years old, is the youngest and in-
home PME and AR/VR device user, and the only female
in this study. She is a transfemoral amputee who lost her
leg in a motor vehicle accident in 2009, when she was 18
years old. S4’s phantom limb pain began almost immedi-
ately after her amputation and was, as she describes,
“excruciating”. S4 was prescribed a heavy dosage of oxy-
codone to manage her pain. For nine years, she continued
taking oxycodone pills consistently. The pill was the only
thing that allowed her to sleep, to escape what she called
a “gnawing, annoying, relentless” sensation. She did not
pursue any other pain management treatments during this
time but was troubled by the strength of the medication
and its numbing effects. In 2017, S4 was trained in PME
and the AR/VR device in lab settings, upon which she
took the device home with her. She continued the treat-
ment at home, allowing periods of complete cessation of
oxycodone.
Intervention: Home Use System
The PME treatment facilitated by MPR, VR/AR, and SG
has been extensively described previously for the upper
limb6,7 and for the lower limb.10,11 The same treatment
methods were employed in this study. Brieﬂy, motion
intent is inferred via MPR using myoelectric activity
from the stump musculature. First, the MPR algorithm is
trained by recording the myoelectric signals associated
with the phantom motions to be exercised. Once the
aimed motions are trained and thus recognized by the
decoder, these can be used to command the following
virtual environments:
Dovepress Lendaro et al
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1. A VR environment featuring a virtual limb that is
freely controlled by the subject.
2. An AR environment to allow the subject to visua-
lize themselves (in real-time) with a virtual arm/leg
superimposed on their stump. The AR environment
uses a conventional webcam which inputs a video
feed that is analysed to track a ﬁducial marker, thus
allowing the virtual limb to remain in the anatomi-
cally correct position while the subject moves.
3. A racing game (Trackmania Nations Forever, free
version) controlled by the subject’s limb movements.
4. Target Achievement Control (TAC) test initially
introduced by Simon and colleagues12 and used in
this study as implemented in BioPatRec.13 The test
requires the subject to match target postures pre-
sented in random order on the screen. The subject
attempts to match the posture by moving the virtual
limb with accuracy (i.e. the target posture can be
overshot) and within a 10-second interval.
A user-friendly system (software and hardware) was
developed for independent use at home. The software
included a pain survey to monitor the level of PLP based
on the Short Form of the McGill Pain Questionnaire (SF-
MPQ) since prior clinical evidence gathered from patients
using our system indicated this metric as the most sensi-
tive measure of changes in pain.7 Although subjects in this
study were free to use the system according to their needs
and to best suit their lifestyles and schedules, the recom-
mended regimen was two sessions per week for at least
90 mins of training (this regimen has demonstrated efﬁca-
cious in our previous clinical experience). Patients were
also asked to occasionally ﬁll in the pain survey in order to
monitor the long-term proﬁle of their PLP.
Data Collection and Outcome Measures
Data concerning the use of the system was stored in the soft-
ware and collected at the end of the one-year study period. We
monitored the frequency of the sessions, number of recording
session per session and number and type of motions per
recording session. Data regarding pain was collected through
the self-administered questionnaire included in the software,
which reports dates and times. The subjects were instructed to
ﬁll in the questionnaire at the end of every training session.
The outcome measures considered were:
● Treatment adherence: Monitored as the number of
sessions carried out monthly.
● Session duration: Inferred from the timestamps of the
recording sessions as the time elapsed between the
ﬁrst and last recording of the day. This time interval
was then increased by the average time between two
consecutive recording sessions in order to account for
the time spent in virtual environments by training
with the last recording session.
● Pain Rating Index: Computed as the sum of the
scores for all descriptors of the Short Form of the
McGill Pain Questionnaire (SF-MPQ).14 The SF-
MPQ consists of 15 pain descriptors rated on
a 4-point scale from 0 to 3. The range of the PRI is
therefore 0 to 45.
Due to the small sample size and variations in patients’
home situations, lifestyles and personal preferences, this
study was not conducted as a clinical trial, nor does it draw
conclusions of statistical signiﬁcance. Rather, it is a series
of case studies following patient progress through the
therapeutic regimen.
Ethnographic Methods
In-depth, unstructured and non-directive interviews15 lasting
from 60–90 mins were conducted with each patient in their
home environments. The interviews were aimed at elucidating
patient narratives,16,17 medical history, prior experience with
phantom limb pain and treatment therapies, and the broader
holistic context of the person’s life, family, hobbies, motiva-
tions, and personality. Yet acknowledging that people do not
always readily articulate their behaviors and practices when
asked about them, these interviews were complemented by
participant observation18 during rehabilitation. Employing
a patient-centred approach to ethnography,19 which empha-
sizes intimate attention to an individual’s subjective and emic
“experience-near,” the anthropologist followed subjects in
their homes, chronicling their strategies for navigating every-
day life with their devices. These engagements reach beyond
what subjects say in self-report into the realm of embodied
practice.
Survey of Use Preference
A self-report questionnaire was administered to identify how
long the subjects used each training exercise as well as
whether they preferred a certain type over the other. In addi-
tion, the subjects were asked in an open-ended question for
feedback about possible improvements of the system for
home use. The results from the self-report survey were incor-
porated with the ethnographic data using the KJ Method to
Lendaro et al Dovepress
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develop insight into the themes and relationships among the
qualitative data20. The basic steps of the KJ Method are as
follows. First, quotes are extracted from a qualitative data
source, such as interviews or surveys, and written down on
separate cards. The quotes are then scanned to identify com-
mon themes, and subsequently grouped together under the
headings of these themes. These classiﬁcations are inherently
subjective and decided upon by the researcher(s)’ interpreta-
tion of the data. Further naming and subclassiﬁcation of the
assorted groups is then performed as needed. This classiﬁed
data from the KJ Method was used to identify user types and
suggest future requirements from the therapy regime.
Results
Usage data for the four participants were gathered over
one year of study and are summarized in bar graphs showing
adherence to the treatment, and in histograms showing the
distribution of session durations. Self-reported pain levels
over time are illustrated as trends of Pain Rating Index (PRI)
over time. All the data are summarized per subject and
illustrated in Figure 1–4 (one ﬁgure per subject), which
consists of three panels (A–C). The results of the survey
about use preferences are reported in Table 1.
Panel (A) of Figure 1–4 reports the trend of the self-
reported level of pain as estimated by the PRI (range
0–45), presented as monthly average. The typical pain
descriptors chosen by each subject are reported in the
respective captions: as it can be noted from all ﬁgures,
the level of pain remained relatively constant and low over
time. Consequently, the pain descriptors also held stable,
showing mild variations only within the individual ratings.
Each of the adherence bar plots (panel (B) in Figure 1–4)
condense information about therapy adherence as percentage
of the suggested monthly sessions carried out by each partici-
pant. Biweekly training (eight sessions per month) was con-
sidered the optimal treatment frequency. For example, the ﬁrst
bar of Figure 1B shows a treatment adherence of 137.5%,
meaning that Subject 1 carried out 11 training sessions during
the ﬁrst month. Note that the subjects started the home treat-
ment in different months; it ensues that “month 1“ in the x-axis
does not correspond to a speciﬁc month but rather the start of
the treatment for that speciﬁc subject. The number on top of
each bar represents the average number of movements per
recording session month by month. The training software
theoretically allows the user to train up to 18 movements
simultaneously. However, patients can rarely achieve above
six movements due partly to the limitations posed by MPR
with surface EMG and a limited number of recording channels
(up to eight, in the device used).Reporting themonthly average
of movements performed per recording session is taken to
Figure 1 Panel (A) presents the self-reported level of pain as expressed by the Pain Rating Index (the sum of the scores give to the chosen McGill pain descriptors) over
time (x-axis). The range of the PRI is between 0 and 45 however the range of y-axis of this graph has been reduced to 0–15 to improve the quality of the data visualization,
since this is the interval containing the PRI for all participants. The value presented in the graph is the monthly average (y-axis). Pain level was not reported in those months
where no data points are shown. (B) Treatment adherence data expressed as percentage of the suggested treatment frequency (eight sessions a month). The number
presented on top of each bar represents the average number of movements trained in a given month. (C) Histogram of the session duration, each bar represents the
number of session (value on the y-axis) of a given length (value on the x-axis). Figure 1 presents data relative to Subject 1. The only pain descriptor reported by Subject 1 is
hot-burning.
Dovepress Lendaro et al
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indicate the complexity of the exercises carried out: the more
movements trained within the same recording session, the
higher the complexity of the classiﬁcation task for the MPR
algorithm. An increasing number of movements requires
superior motor skills of the stump musculature in order to
maintain quality performance with the VR/AR and SG
environments.
From this way of presenting adherence data, it becomes
clear that over the course of the ﬁrst seven months the usage
frequency generally decreases among all subjects. Subject 1
starts in January and interrupts the treatment between July
and September, resuming the therapy with 100% adherence
in October. S2 starts in August but phases out completely by
March. S3 starts in December and trains throughout the
Figure 2 Data relative to Subject 2 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 2 were: throbbing, shooting, stabbing and aching.
Figure 3 Data relative to Subject 3 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 3 were: throbbing, stabbing, sharp, gnawing, hot-burning, aching and splitting.
Lendaro et al Dovepress
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whole year: the frequency of training decreases in over
summer months only to increase again during the following
winter. S4 starts in October and trains with decreasing fre-
quency over the following 7 months; after a long interruption
of four months, she returns to therapy at the end of the
monitoring year.
The complexity of the movements appears idiosyncratic;
for each subject such idiosyncracy remains relatively con-
stant over time. Session duration, in panel C, is presented in
the form of histograms and indicates that all subjects spent
less time training than the advised 90 mins, but also shows
a large within-subject variation of session length.
Figure 4 Data relative to Subject 4 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 4 were: cramping, gnawing, heavy, tender, tiring-exhausting, punishing-cruel.
Table 1 Self-Reported Use Preferences Using PME Device
Self-Reported Use Preferences S1 S3 S4
Therapy Duration 1.5 hrs-2 hrs 1 hr-1.5 hrs 1.5 hrs-2 hrs
Average TAC Time 0–10 mins More than 20 mins 15–20 mins
Average AR Time More than 20 mins More than 20 mins 0–10 mins
Average VR Time I do not use the VR Limb More than 20 mins 0–10 mins
Average Game Time 0–10 mins I do not use the race car game I do not use the race car game
Preferred Exercise AR Limb TAC Test TAC Test
Factors that Prevent you from doing
therapy
Time Shortage Number of Electrodes Time Shortage
What additional assistance do you
need to carry out the session
None Not needed, practiced many times
and learned by doing
Someone who feels where to place
the electrodes on the muscles
Progress Marker Increase in Sleep, decrease
in daily pain levels
Pain decreases by 30–50% -
Open Recommendations - Reusable Electrode interface, shorter
treatment times more often
More exercises with a goal to reach,
and reduce timing
Abbreviations: PLP, phantom limb pain; MPR, myoelectric pattern recognition; PME, phantom motor execution; AR/VR, Augmented and Virtual Reality; SG, serious gaming;
TAC, Target Achievement Control; SF-MPQ, Short Form of the McGill Pain Questionnaire; PRI, pain rating index; PMI, Phantom Motor Imagery.
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Table 1 displays the results of the user preference
survey. It was not possible to survey S2 because he termi-
nated the use of the device several months preceding the
interview time. From these results a discrepancy emerges
in the estimate of time spent training as inferred from the
data stored in the software (panel C of Figure 1–4) versus
the data reported by the users themselves (Table 1), with
the latter always exceeding the former.
Ethnographic Results
Ethnographic results are ﬁrst presented for each subject,
followed by ethnographic analysis of cross-cutting themes
among all subjects, elucidating four key ﬁndings. All
descriptors regarding the therapy and pain experiences
that are contained in quotations are subjects’ own words
from interviews with the anthropologist. These descriptors
were chosen by the subjects themselves, elicited through
their own free-associations, rather than offered as prompts
in the interview. Descriptors regarding therapy and pain
experience that are not contained in quotations are the
anthropologists’ observations and interpretations drawn
from participant observation as well as themes present in
the interviews.
S1 reported a shift in frequency and consistency of his at-
home treatment, largely depending on his level of present
pain and corresponding motivation. For the ﬁrst few years
using PME at-home, S1 practiced the therapy regularly:
It was much simpler for me to use the system at home.
I started with ambition. If I did it every day, what would
happen? For a time I used it every other day, just to see if
the pain were to disappear even more, but there actually
wasn’t too much of a difference.
After a few months of frequent sessions at home, S1 was
able to stabilize his pain levels with less regular intervals
of the therapy. When pain was manageable, S1 deprior-
itized the therapy. “I wish I did it a bit more often,” S1
admitted. “I’m not hindering you!” S1’s wife chimed in.
S1 acknowledged that his wife often reminds him to prac-
tice the therapy, citing that she can “sense a difference”
when he has been more regular with the treatment. Still,
“life gets in the way,” as he explained, and sometimes
weeks pass between his treatment sessions:
It’s easy to say ‘no, I have to do this ﬁrst.’ So that is the
problem when one is responsible at home for their own
treatment. One must prioritize the treatment. When I start
to feel that the pain is becoming a problem again, then
I prioritize it. When the pain isn’t so bad, I think ‘not just
now, I can do it tomorrow.
Here, S1 highlighted the challenge of in-home treatment
maintenance when pain is not so present or acute and that
the use of the therapy is often driven by current pain level.
S1 reported that he typically performs a treatment session
for two hours. Despite years of using the AR/VR device, S1
continued to ﬁnd enjoyment and novelty in the treatment.
“It doesn’t feel like (two hours) because it takes so much
concentration, it’s so fun even after all these years . . . it’s
not very easy, it requires concentration, it isn’t the same
every time,” he reﬂected. S1 progressed through all four
activities but tends to prefer the AR conﬁguration and the
TAC test. A former professional race car driver, S1 enjoyed
playing the game, especially delighting when he can steer
the car with movements from his little ﬁnger, motivated by
reaching a “best time.” Despite his familiarity with the
device, some elements, including electrode placement on
the skin of the residual limb to record clear myoelectric
signals, remained “challenging” throughout the course of
the study. From time to time signal quality still varies. One
time I got such good signals that I took a permanent pen
and marked on my skin where they were. But it washed
away after a few showers. This one is easy, he points to one
electrode that lay just above a scar, “I just follow the scar
slightly up.” As S1’s description demonstrates, in-home use
of the AR/VR device requires learning and knowing the
locations on one’s body in relation to signal quality. During
one treatment session, the anthropologist noticed S1
whispering under his breath, intently focused on the virtual
on-screen hand, coaxing the little ﬁnger as if he were
addressing a young child. This moment evinced the degree
to which patients like S1 envision the virtual arm as inti-
mately connected to the user’s own body – if not a virtual
representation of one’s own phantom hand, then at least
something which they can guide and control with effort and
positive self-talk. “The best part is when I can control these
little ﬁngers here,” he points to the fourth and ﬁfth ﬁngers.
“That happens just a few days a year. It happened just three
nights ago!” This challenge—seeing if he can control the
two little ﬁngers—seemed to drive each and every treatment
session, his barometer of success. “The brain realizes that
one can move the little ﬁngers; it realizes they (still) exist
there,” he explained. His invocation of the brain speaks,
uncannily, to the underlying theory of PME.
S2 is a unique patient in that he adapted PME therapy
to not require the use of the AR/VR device, a regimen he
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calls “in-head exercises.” S2 ceased the use of the device
because he felt only a few minutes of training was neces-
sary to achieve pain relief, and this was not worth the time
required to place the electrodes. When the research team
visited S2 at his home, they were most interested in better
understanding how he practices PME without the AR/VR
device. It was crucial to ensure S2 was not merely envi-
sioning or imagining the movements in his mind (which
would purportedly only engage Phantom Motor Imagery
[PMI]) but rather that he was actively engaging the muscle
groups around the stump to execute movement in the
phantom arm and hand (purportedly engaging the sensor-
imotor system). S2 described his method as such: He sits
or lays on the sofa and tries to relax, directing his attention
to the phantom pain (which he otherwise tries to avoid it
through distraction). He ﬁrst thinks about the movement,
then performs the movement, feeling the muscles in his
residual limb contract. In this description, S2 made a clear
distinction between passively thinking and actively per-
forming the movement, signaling to the research team that
he was in fact engaging the muscles in the way PME
intends. Like the other three subjects, S2 developed his
own routine for practicing PME, yet his was more frequent
with a much shorter duration: he trained roughly four
times a day, for just one to two minutes at a time. The
exercise he most often performed was opening and closing
his phantom hand. It took only one minute before he
started to feel the pain diminish. Still, S2 continued to
take oxycodone to manage his pain every day. However,
he has greatly decreased his intake of pain medications,
halting his earlier use of morphine plasters and using low-
dose tablets instead. Still, it appeared that PME exercises
served as a supplement, while morphine remained his ﬁrst-
line treatment. Interestingly, even though they did not
currently have an AR/VR device at home, S2 and his
wife took meticulous care of its operating instructions,
which they kept in a binder with pages laminated. In this
binder, they had pictures of S2’s stump with the electrodes
placed in their optimal position for producing the clearest
signals (his physiotherapist’s idea). Even despite his cur-
rent non-use of AR/VR device, S2 acknowledged its
importance in initiating his own treatment practice.
“Without the device, I would have never come up with
this method,” S2 said, referring to his “in-head exercises.”
S2’s case testiﬁes to the possible efﬁcacy of PME inde-
pendent of the therapeutic technology developed and tra-
ditionally used to facilitate it.
S3 was the subject who most enlists his family’s help
in the therapy’s practice. His wife participated actively in
each session, helping him set up the device, place the
electrodes on his stump, and navigate the program’s var-
ious activities on the laptop. His son was often involved as
well, troubleshooting when the program has any technical
difﬁculties, and was also the main point of contact
between S3 and the researchers. S3 also created the most
strictly regimented schedule for his PME treatments, built
into his family’s weekly routine: every Monday and
Thursday, around 5 or 6pm, before dinner. Each training
session, S3 began with a different leg movement. After
completing the recording session, he skipped the Virtual
Reality portion of the treatment, often preferring the
Augmented Reality version. In fact, he spent a majority
his time with AR/VR device using the Augmented Reality;
he disliked the car racing game as he found it tedious and
difﬁcult to control (“I just kept crashing the car”). S3’s
son, who was actively involved in the treatment, encour-
aged his father to use the TAC test, reasoning that “it’s
better because there’s something to follow . . . so you know
what you’re doing,” but S3 seemed to prefer using the
Augmented Reality for its videocam representation of
himself, the room, and his virtual leg. The anthropologist
visited S3 twice – ﬁrst with the research team and then
alone – and found that the patient responded positively to
the research team’s suggestions and advice with regards to
adherence and motivation. On the ﬁrst visit, the patient
seemed to be struggling with the treatment and unabated
pain. A researcher identiﬁed S3 failed to follow the treat-
ment instructions. S3 had not been increasing the level of
challenge by performing new movements. The researcher
then stressed the importance of this progression for the
efﬁcacy of the therapy. On the follow-up visit, the anthro-
pologist observed a marked behavioral, even emotional
shift in the patient’s interaction with the technology. S3’s
stamina and tolerance appeared much higher, he grew less
frustrated with the system, and the overall sense of moti-
vation, enjoyment, even “belief” (his own descriptor) in
the therapy, seemed much higher by the end of the study.
Concomitantly, the patient reported a “reduction” in his
phantom pain in the weeks following the implementation
of a refocused approach, as per the research team’s advice.
Of all in-home patients, it seemed that S3 and his family
had folded the AR/VR device into their home environment
in the most intimate way, with speciﬁc household arrange-
ments that facilitated the technology’s use. Unlike the
other patients, who used their laptop screen for the
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treatment, S3 broadcasted the AR/VR exercises from his
laptop onto a large TV screen in the living room. His wife
and he purchased the laptop speciﬁcally for using the PME
software. They stored the laptop and device on a roller-
cart, which they covered with a towel, the same towel that
S3 later placed on top of a chair to sit on when he per-
forms the treatment. S3 and his wife have appropriated
other everyday home objects into helpful tools that
enabled the use of the AR/VR device. Since the reference
electrode placed on S3’s wrist often slipped due to sweat,
they regularly placed a rubber band around it. S3 and his
wife pasted the AR-reference, a barcode-looking piece of
paper used to track the virtual arm onto the webcam of the
patient’s body, onto the cover of an old hardcover book,
which they placed at the foot of S3’s chair when not in
use. S3’s wife also recorded S3’s activity scores in
a handwritten notebook, actively participating in her hus-
band’s treatment. This manual progress-tracking consti-
tuted a form of care and sociality formed around the
therapy.
S4 began her in-home PME treatment on the sugges-
tion of a friend who was familiar with the treatment. She
began to notice that it was “working” (her term) when one
night, two months after she started the treatment and for
the ﬁrst time in nine years, she forgot to take her oxyco-
done pill. To her surprise, she slept an entire night without
pain. She then continued ceasing her pills for one month
but kept practicing PME. Several weeks later, she also
stopped her PME treatment, thinking “it had worked”
and was no longer necessary. But one month later, the
PLP and disrupted sleep returned. This initiated a period
of titrating between oxycodone and PME. S4 took the pill
on and off, and began training with AR/VR device again,
just twice a month. Five months after initiating the in-
home treatment, she had continued this titration process,
moving between sporadic oxycodone use and sporadic
PME training to regulate her pain. S4 found that when
she is not taking oxycodone, she was “more awake, ener-
getic, less groggy,” and had more responsive reﬂexes. At
the beginning of her treatment, S4’s at-home PME ses-
sions would last 1.5–2 hrs. After several treatments, she
reduced their duration to 1–1.5 hrs. While at the outset she
utilized all of the AR/VR device activities (VR, AR, TAC
Test, and gaming), she preferred to use the TAC Test,
ﬁnding it “most helpful and effective” and began focusing
her time and energy solely on that activity. At the time of
the interview, her PME regimen consisted of a recording
session for multiple simultaneous movements and two to
three rounds of the TAC Test, which takes her roughly 1 to
1.5 hrs. For S4, a decrease (or cessation) of oxycodone
signiﬁed the efﬁcacy of PME as a stand-in treatment. Her
assessment of whether the treatment was “working” chan-
ged over the course of the study in proportion to her use of
it (more consistent use correlated to greater perceived
efﬁcacy). Her approach to focusing on the TAC Test also
evinced an optimization of the treatment to ﬁt her needs,
a personalization of the therapy. S4’s afﬁnity with the TAC
Test spoke to her broader identity as a professional athlete,
motivated by the pursuit of scoring points and reaching
goals. As S4 explained, “The TAC Test is an exercise
where you have to reach the goal.” She described this
goal-reaching aspect as motivating; a higher score yields
greater satisfaction. After several months of using the AR/
VR device, she expressed that she had identiﬁed how to
reach a higher score: she must optimize the electrode
placement positioning on her stump. S4’s goal score for
each treatment session was 100%; she repeated the test
until she reached as close as possible and attempted to
repeat this two or three times. As such, her treatment
session was guided less by a speciﬁc set time length, or
by the progression through the PME exercises, but by the
achievement of her self-identiﬁed “goal” (100% on the
TAC Test). S4 found the AR/VR device itself a bit cum-
bersome; the software was not compatible with her Mac
laptop, so she had to borrow her grandmother’s PC laptop.
S4 learned to place the electrodes on her stump herself but
enlisted the help of friends in their placement, as well as
over Skype with the research team in Gothenburg.
The analysis of ethnographic research elucidated the
following four key ﬁndings:
1. Subjects developed their own PME routines sur-
rounding frequency of practice and which activities
they prioritize (and deprioritize). These routines
varied from several-minute micro-sessions practiced
four times daily (S2), to regularly scheduled bi-
weekly evening sessions (S3), to more sporadic ad-
hoc use based on severity of pain and perceived
“need” for the treatment (S1 and S4). Subjects
worked the treatment into the contexts of their
everyday lives and saw the value of being able to
practice the therapy on their own time without hav-
ing to travel to the clinic. At the same time, some-
times life “gets in the way” (S1) and postponing or
skipping treatment sessions became easier when
competing with the demands of everyday life.
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When this disruption occured, returning or increas-
ing pain signaled to those without a regular PME
schedule the need to re-prioritize their treatment.
2. Subjects customized and personalized PME to ﬁt
their bodies, pain levels, personalities, interests,
and lifestyles. In doing so, they cultivated ways to
stay motivated and engaged in the therapy. Patients
personalized by prioritizing the AR/VR device
activities that best align with their needs. S1 per-
formed all activities sequentially, emphasizing the
AR conﬁguration and gaming, gauging his perfor-
mance by his ability to move the fourth and little
ﬁngers of his phantom hand independently. S2 per-
formed PME independent of the AR/VR device,
thus proving the potential viability of the therapy
absent of the device and its activities. S3 focused
almost exclusively on the AR conﬁguration, which
he enjoyed most for its real-world reﬂection of his
home environment, but also performed the TAC
Test on the encouragement of his son, who believed
it was more goal-oriented and thus motivating. S4
prioritized the TAC Test for its feedback of
a percentage-based score; the pursuit of 100%
tapped into her athletic goal-oriented motivation.
3. For most subjects, PME ﬁt within the wider context
of a pain management regimen. For three out of the
four subjects, it was a supplemental treatment used
in the context of continued low-dose pain medica-
tions, abating the need for higher dosage. While S1
had completely ceased use of pain medication since
using PME, S2 and S3 still took low-dose pain
meds daily. For these subjects, PME was
a supplemental treatment that allowed them to man-
age their pain on a lower dose. S4 vacillated
between taking pain meds and using PME, but
unlike S2 and S3, she alternated these treatments
rather than using them concomitantly.
4. In-home, the device became “domesticated” materi-
ally, contextually, and socially. Subjects like S3
recruited and adapted everyday home objects
(books, roller carts, rubber bands etc.) into supple-
mental objects in the use of the AR/VR device,
folding in the device into the material context of
the home. In this way, it can be said that the device
took up residence in subjects’ households. Family
members (in the case of S1 and S3) participated in
the treatment – actively, in the case of S3, whose
wife navigated the software interface and placed the
electrodes on her husband’s limb, and passively, in
the case of S1, whose wife reminded and encour-
aged him to practice the therapy regularly. Thus, it
was not only the subject, but also family members
who engaged with the device both directly and
indirectly.
Identiﬁcation of User Types
The information regarding the use of the system was
extracted from the ethnographic unstructured interviews
and analyzed using the KJ methodology: Figure 5 sum-
marizes the resulting workﬂow.
Proceeding subject by subject, the anthropologist read
aloud relevant sections of the unstructured interview refer-
ring to the use of the system. The user researcher wrote
down quotes and paraphrased information on separate
cards. After reviewing each subject interview, the user
researcher then organized the cards according to the
themes that emerged: Personalized Dosing, Assistance/
Support System, Deﬁnition of Progress, Motivation,
Faith in Therapy, Storage of Device, Patient
Improvisation, Electrode Placement and Tracking
Progress. After studying these nine themes, the user
researcher and anthropologist searched for discrepancies
in themes within the groups to create further subgroups.
The categories with notable discrepancies in themes
included subjects’ approaches to personal dosing, their
deﬁnition of progress, their faith in therapy and their
motivations for performing the therapy. The data under
these categories was then subdivided into the two user
types: the goal-oriented user and the experiential user.
For the remaining ﬁve categories, no subcategorization
was needed.
These user types are archetypes, informed by but not
directly reﬂecting any one individual patient, used solely
to contextualize the functional requirements for the design
of the user interface. In some cases, patients straddled the
two user types. The survey results support these two user
types and also demonstrate differences in the time patients
spend on each AR/VR activity.
User Type I: Goal Oriented User
These users mark their progress with PME based on com-
pletion of a goal, rather than cumulative time passed, and
prefer goal-oriented activities such as the TAC test over
time-based activities like AR or VR. These users could be
more interested in feedback from the therapy in terms of
markers for completion of certain goals. S3 and S4 both
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exhibit patterns of a goal-oriented user in that they both
exhibit a preference to the TAC Test (see Table 1), in
which the user strives to achieve a goal movement.
While S3 identiﬁes the TAC test as a preference, he also
practices often with the AR limb, which also corresponds
to User Type II patterns, indicating that user preferences
are not always clear-cut between the two types.
User Type II: Experiential User
These users see the therapy regime through the scope of
the AR experience, which renders the user’s physical body
and the virtual limb in the same screen using a webcam,
also reﬂecting their actual environment. The Experiential
User may place more importance on the realistic qualities
of the AR limb in terms of sizing, colour and shape as well
as how responsive and realistic the virtual limb is with
regards to the user’s perception of their phantom limb.
This user will often base their practice more on a time
marker than achieving a speciﬁc movement goal. This
pattern of use was ascertained in observation of S3’s pre-
ference for experiential practice through motor execution
and S1s self- preference (see Table 1). It must be noted
that patients may enter PME with previous experience
from other forms of pain management therapies, including
mirror therapy,21–23 where visual feedback is considered
the main conducive of pain relief: In these cases, the
verisimilitude of the anthropomorphic feedback is of
paramount importance. This introduces a potential discre-
pancy between the goal of PME therapy, which is based on
the improvement of the motor execution, and the user’s
expectations and goals. This may translate into
a preference for the anthropomorphic components of the
PME therapy, such as the AR, disfavoring those compo-
nents that do not involve a virtual limb, i.e. the racing
game. Furthermore, mirror therapy sessions may be based
off of practicing for a set amount of time rather than
reaching a motor execution goal. In order to address this
potential user bias and translate it into the new underlying
theory of PME, a time-aware software interface should be
developed in order to deliver feedback on the time spent at
each level of movement difﬁculty (single degree of free-
dom movements, multiple degree of freedom movements,
simultaneous movements) and motivate the patient to
attempt more complex movements or to test their skills
after the experiential practice.
Discussion
This study demonstrates the adaptability of a technological
therapy (PME) to treat PLP in the home, where patients
drive its usage. Hypotheses on the working mechanism of
PME as a treatment of PLP, as well as for the genesis of
the condition itself, have been discussed at length by
Ortiz-Catalan along with clinical results and potential con-
founding factors.1 The purpose of this study was not to
Figure 5 Flowchart presenting the steps and the results of the KJ analysis.
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assess therapeutic efﬁcacy but rather to interpret how
a previously clinical therapy can be translated into home
contexts, at the user’s discretion. Subjects were instructed
to use the AR/VR device at will, adapting it to their needs.
The adherence data indicates that patients use the system
more intensively in the ﬁrst weeks of receiving the device,
and then diminish their usage as pain decreases, as evi-
denced by lapses in use. Use is taken up again in an ad-hoc
fashion, at need, often driven by the recurrence of pain. As
a consequence, the pain graph might not necessarily depict
how the treatment affects patients’ pain, but rather how
their pain level drives the use of the therapy. Treatment
adherence, then, changes depending on patients’ needs.
This tight coupling and interplay between pain, per-
ceived need, and use requires a multidisciplinary
approach. Alone, the pain rating does not reﬂect every-
thing about the intricacies and motivations driving (or
deterring) a patient’s in-home device use. Therefore, we
involved an anthropologist and user interface designer,
along with their qualitative methodologies, to better under-
stand use behaviors, patterns, and barriers. Their analysis
indicates that users’ proﬁles differ depending not only
upon their needs, but also upon their motivations and
daily life contexts. Patient adherence is especially impor-
tant in this form of therapy because of the underlying
mechanisms of PME.1 This makes understanding and
designing for different user groups and understanding
user expectations a critical task to improving the adher-
ence and outcome of the therapy regime at home.
The self-reported use preferences indicate two key bar-
riers to adherence. The ﬁrst is time. The therapy demands
signiﬁcant time (one to two hours per session), requiring the
patient to incorporate the regimen into their everyday life.
The second barrier is the need for reusable electrodes. The
cost and availability of single-use electrodes can make the
therapy prohibitively expensive or inaccessible and therefore
could decrease adherence to therapy regime.
In order to design a device compatible with multiple
user types, the following functions are recommended. For
the Experiential User, a time display recording both dura-
tion and frequency will allow for tracking and recording
within the interface. AR should be further developed to
meet variations in skin color, nail color and size of limb, to
expand relevance to wider, more diverse user populations
and enhance their engagement. For the Goal Oriented
User, feedback on results (i.e. movement accuracy mea-
sured by the TAC test, level of complexity of limb move-
ment combinations) should be displayed to drive
motivation. Additional goal-oriented activities and mar-
kers could recognize accuracy on different combination
of movements. Indeed, the average number of limb move-
ments shown in panel B of Figure 1–4 does not evidence
any signiﬁcant increase over time, indicating a need for the
software to prompt the patients to increase difﬁculty.
Users should be enabled to set personal goals for the
therapy using different measures of success (i.e. Increase
Movement Accuracy, Decrease Pain, Improve Sleep
Quality). User data (adherence, TAC scores, time) should
be comprehensively presented as a form of feedback and
self-monitoring. This underscores the need for ways to
track long-term progress, considering breaks in therapy
and consequent need to refresh PME skills. Finally, feed-
back on progression and level of complexity of move-
ments needed in therapy will make treatment sessions
more efﬁcient.
The main limitations of this study include a small
sample size (n=4). The inherent variability of patients’
home situations makes generalizability difﬁcult, but also
serves to demonstrate the versatility and ﬂexibility of both
the device and its therapeutic applications. Patients have
adapted the regimen to their home lives and developed
personalized routines. This paper is a proof of concept.
Future research should focus on a more systematic and
robust investigation on the home use of the device, includ-
ing compliance over a longer period of time.
Conclusion
This study holds methodological relevance for a broader
research context beyond that of phantom limb pain.
Healthcare services and therapeutic technologies are
increasingly moving outside of the clinic into the home,
a global trend growing with the digitization and develop-
ment of artiﬁcial intelligence and user-friendly design.
This domestication of health technology raises both new
possibilities and challenges, as well as creates unprece-
dented encounters between humans and technologies in
their own domain, demanding a new approach to studying
these relations. This paper offers an example of how to
study and monitor the use of such health technologies in
the home. By including the social expertise of a medical
anthropologist and the human-machine interface expertise
of a user interface designer, we approach this phenomenon
holistically adding a social perspective to a question that
would normally be answered in terms of clinical and
quantitative data. What emerges is a more nuanced picture
of the motivations, barriers, and desires driving patient-led
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in-home care, which in turns is used to design interven-
tions that increase the technology’s capacity and relevance.
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